Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hemorrhage × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 22 Classical hematology 11 Other hematologic neoplasm 9 Genitourinary 9 Lymphoid 4 CNS 4 Plasma cell 3 Thoracic 2 Other 2 Gynecologic 2 Sarcoma 1 Myeloid 1 Head & Neck 1 Endocrine 1

Conditions

Sarcoma 1303 Glioblastoma 445 Gliosarcoma 425 Osteosarcoma 375 Brain Neoplasms 298 Gastrointestinal Stromal Tumors 276 Central Nervous System Neoplasms 263 Dendritic Cell Sarcoma, Interdigitating 245 Neoplasms 244 Astrocytoma 239 Lymphoma 221 Bone Neoplasms 208 Sarcoma, Ewing 204 Neuroblastoma 204 Glioma 204 Breast Neoplasms 203 Rhabdomyosarcoma 193 Lymphoma, Non-Hodgkin 189 Melanoma 186 Precursor Cell Lymphoblastic Leukemia-Lymphoma 184 Burkitt Lymphoma 182 Recurrence 180 Oligodendroglioma 177 Ovarian Neoplasms 166 Lymphoma, Large B-Cell, Diffuse 161 Neoplasm Metastasis 157 Lymphoma, Follicular 146 Leukemia 141 Leukemia, Lymphocytic, Chronic, B-Cell 134 Hodgkin Disease 133

Interventions

Tranexamic Acid 1 Fibrin Tissue Adhesive 1 Diathermy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡